Sandoz to invest in Ljubljana drug-substance facility to expand biosimilar capacity
Sandoz Group AG plans to invest in a new drug-substance facility in Ljubljana, Slovenia, to expand biosimilar manufacturing capacity.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.